Pivalopril
Pivalopril is a new orally active angiotensin converting enzyme (ACE) inhibitor.
Product Specifications
CAS Number
81045-50-3
Product Name Alternative
Pivopril; RHC 3659 (S)
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Pivalopril.html
Purity
99.19
Solubility
DMSO : 90 mg/mL (ultrasonic)
Smiles
O=C(O)CN(C1CCCC1)C([C@H](C)CSC(C(C)(C)C)=O)=O
Molecular Formula
C16H27NO4S
Molecular Weight
329.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Burnier M, et al. RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers. Br J Clin Pharmacol. 1981 Dec;12 (6) :893-9.|[2]Wolf PS, et al. Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659- (S) ) . Fed Proc. 1984 Apr;43 (5) :1322-5.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033103-01 10 µg
Recombinant Human TGOLN2/TGN38 Homolog Protein (His Tag)
Sign In for Pricing
View Details PKSH033103-02 50 µg
Recombinant Human TGOLN2/TGN38 Homolog Protein (His Tag)
Sign In for Pricing
View Details 
E-CL-H1180-01 24 Tests
Human GDF11 (Growth Differentiation Factor 11) CLIA Kit
Sign In for Pricing
View Details E-CL-H1180-02 48 Tests
Human GDF11 (Growth Differentiation Factor 11) CLIA Kit
Sign In for Pricing
View Details E-CL-H1180-03 96 Tests
Human GDF11 (Growth Differentiation Factor 11) CLIA Kit
Sign In for Pricing
View Details 
BNCB1461-100 1x 100 µL
CD45 / LCA (B-Cell Marker) (PTPRC/1461), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details